Literature DB >> 16886306

Gastroesophageal reflux disease and irritable bowel syndrome: a common overlap syndrome.

Ram Dickman1, Hussain Feroze, Ronnie Fass.   

Abstract

Gastroesophageal reflux disease (GERD) and irritable bowel syndrome (IBS) are very common disorders in the general population. Symptoms of IBS are commonly encountered in GERD patients, and symptoms of GERD are not uncommon in IBS patients. GERD patients consistently report lower abdominal symptoms, which may be part of the spectrum of GERD symptoms. Alternatively, GERD and IBS may be two distinct manifestations of a similar underlying pathophysiologic process that can affect different levels of the gastrointestinal tract. Although the reason for the overlap observed between GERD and IBS remains to be elucidated, recent studies have demonstrated that GERD patients who also suffer from IBS-like symptoms perceive their GERD-related symptoms as more severe and are less likely to respond to antireflux treatment, as compared with those without IBS.

Entities:  

Mesh:

Year:  2006        PMID: 16886306     DOI: 10.1007/s11894-006-0045-1

Source DB:  PubMed          Journal:  Curr Gastroenterol Rep        ISSN: 1522-8037


  26 in total

1.  Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota.

Authors:  G R Locke; N J Talley; S L Fett; A R Zinsmeister; L J Melton
Journal:  Gastroenterology       Date:  1997-05       Impact factor: 22.682

2.  Extraintestinal symptoms in irritable bowel syndrome and inflammatory bowel diseases: nature, severity, and relationship to gastrointestinal symptoms.

Authors:  Joseph Zimmerman
Journal:  Dig Dis Sci       Date:  2003-04       Impact factor: 3.199

3.  International validation of ReQuest in patients with endoscopy-negative gastro-oesophageal reflux disease.

Authors:  K D Bardhan; V Stanghellini; D Armstrong; P Berghöfer; G Gatz; H Mönnikes
Journal:  Aliment Pharmacol Ther       Date:  2004-10-15       Impact factor: 8.171

4.  Functional heartburn.

Authors:  Ram Dickman; Ronnie Fass
Journal:  Curr Treat Options Gastroenterol       Date:  2005-08

5.  Prevalence of functional gastrointestinal disorders in a population of subjects consulting for gastroesophageal reflux disease in general practice.

Authors:  François Guillemot; Philippe Ducrotté; Lionel Bueno
Journal:  Gastroenterol Clin Biol       Date:  2005-03

6.  Irritable bowel syndrome, gastro-oesophageal reflux, and bronchial hyper-responsiveness in the general population.

Authors:  T M Kennedy; R H Jones; A P Hungin; H O'flanagan; P Kelly
Journal:  Gut       Date:  1998-12       Impact factor: 23.059

7.  Altered esophageal pain threshold in irritable bowel syndrome.

Authors:  M Costantini; G C Sturniolo; G Zaninotto; R D'Incà; R Polo; R Naccarato; E Ancona
Journal:  Dig Dis Sci       Date:  1993-02       Impact factor: 3.199

8.  Irritable bowel syndrome in the general population.

Authors:  R Jones; S Lydeard
Journal:  BMJ       Date:  1992-01-11

9.  Identification of distinct upper and lower gastrointestinal symptom groupings in an urban population.

Authors:  N J Talley; P Boyce; M Jones
Journal:  Gut       Date:  1998-05       Impact factor: 23.059

10.  Altered rectal perception is a biological marker of patients with irritable bowel syndrome.

Authors:  H Mertz; B Naliboff; J Munakata; N Niazi; E A Mayer
Journal:  Gastroenterology       Date:  1995-07       Impact factor: 22.682

View more
  8 in total

1.  Influence of irritable bowel syndrome on treatment outcome in gastroesophageal reflux disease.

Authors:  Hubert Mönnikes; Robert C Heading; Holger Schmitt; Hubert Doerfler
Journal:  World J Gastroenterol       Date:  2011-07-21       Impact factor: 5.742

2.  Irritable Bowel Syndrome and Co-morbid Gastrointestinal and Extra-gastrointestinal Functional Syndromes.

Authors:  Ami D Sperber; Roy Dekel
Journal:  J Neurogastroenterol Motil       Date:  2010-04-27       Impact factor: 4.924

Review 3.  Gastroesophageal reflux disease (GERD) and irritable bowel syndrome (IBS)--is it one disease or an overlap of two disorders?

Authors:  Anita Gasiorowska; Choo Hean Poh; Ronnie Fass
Journal:  Dig Dis Sci       Date:  2008-12-10       Impact factor: 3.199

4.  Irritable bowel syndrome and gastroesophageal reflux disease in primary care: is there a link?

Authors:  Ana Ruigómez; Mari-Ann Wallander; Saga Johansson; Luis Alberto García Rodríguez
Journal:  Dig Dis Sci       Date:  2008-08-22       Impact factor: 3.199

5.  Gastro oesophageal reflux disease (GORD)-related symptoms and its association with mood and anxiety disorders and psychological symptomology: a population-based study in women.

Authors:  Livia Sanna; Amanda L Stuart; Michael Berk; Julie A Pasco; Paolo Girardi; Lana J Williams
Journal:  BMC Psychiatry       Date:  2013-07-24       Impact factor: 3.630

6.  Prediction of response to PPI therapy and factors influencing treatment outcome in patients with GORD: a prospective pragmatic trial using pantoprazole.

Authors:  Robert C Heading; Hubert Mönnikes; Anne Tholen; Holger Schmitt
Journal:  BMC Gastroenterol       Date:  2011-05-11       Impact factor: 3.067

Review 7.  Gut microbiota and sirtuins in obesity-related inflammation and bowel dysfunction.

Authors:  Shaheen E Lakhan; Annette Kirchgessner
Journal:  J Transl Med       Date:  2011-11-24       Impact factor: 5.531

8.  Comparing the Effect of Psyllium Seed on Gastroesophageal Reflux Disease With Oral Omeprazole in Patients With Functional Constipation.

Authors:  Mousalreza Hosseini; Roshanak Salari; Mina Akbari Rad; Maryam Salehi; Batul Birjandi; Masoumeh Salari
Journal:  J Evid Based Integr Med       Date:  2018 Jan-Dec
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.